Genprex (GNPX) Shares Outstanding (2016 - 2026)
Genprex (GNPX) recorded Shares Outstanding of 473,162 in Q2 2026, down 62.3% from 1.25 million a year earlier but up 49.7% from the prior quarter.
Powered by 
Analysis
Genprex (GNPX) Shares Outstanding (2016 - 2026) Analysis & Trends
For FY2025, Genprex reported Shares Outstanding of 42,397, down 76.7% from FY2024.
- Annual Shares Outstanding has a five-year compound annual growth rate of -51.7% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 182,091 in FY2024 (+192.9%), 62,170 in FY2023 (-97.1%), 2.18 million in FY2022 (+1.8%) and 2.14 million in FY2021 (+32.6%).
- Quarterly Shares Outstanding has ranged from 34,568 in Q3 2025 to 2.63 million in Q3 2023 over the past five years.
- On a year-over-year basis, Shares Outstanding has declined for four consecutive quarters, with growth averaging 95.8% over the last seven quarters.
- Peak year-over-year performance for Shares Outstanding in the last five years was growth of 843.3% in Q1 2025, against a decline of 97.1% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 316,000 (Q1 2026), 42,397 (Q4 2025) and 34,568 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Genprex | 1.48 Mn | -40.66 Mn | - | 473,162.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 473,162.00 |
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 42,397.00 |
| Sep 30, 2025 | 34,568.00 |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 693,875.00 |
| Dec 31, 2024 | 182,091.00 |
| Sep 30, 2024 | 159,082.00 |
| Jun 30, 2024 | 98,271.00 |
| Mar 31, 2024 | 73,556.00 |
| Dec 31, 2023 | 62,170.00 |
| Sep 30, 2023 | 2.63 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | 2.18 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 2.16 Mn |
API Access
Genprex Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GNPX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "GNPX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GNPX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();